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Editorial
Adolescent tuberculosis
One of the most intriguing features of the epidemiology of
tuberculosis is the well-known variation in the age incidence
of disease and the variation in the nature of the disease with
age.
During infancy and early childhood, tuberculous disease is
particularly liable to follow infection and high morbidity and
mortality are experienced.' Disseminated forms of disease,
such as miliary tuberculosis and tuberculous meningitis, are
particularly likely to develop. Respiratory
tuberculosis in young children is mainly related to
the primary complex and the progression of one or
more of its components. Cavitation can occur in
young children, but is unusual.2
Between the ages of about 5 and 10 years,
children enter a period of relative protection from
tuberculous disease, despite a persistent risk of
infection as evidenced by an uninterrupted rise in
the proportion o~ children with a positive tuberculin
test. In South Africa, between 1970 and 1980, the
tuberculosis case fatality rate was 7% for children < 1 year
of age falling to 3% for those 1 - 4 years and 1% for those
5 - 9 years.3After the age of 10 years, however, an ever-
increasing risk of tuberculous disease is experienced and
the nature of the disease changes from primary to adult-type
tuberculosis:' In South Africa there is a threefold increase in
the risk of developing tuberculosis as children pass through
adolescence to young adulthood. In the Western Cape this
risk is increased sixfold.s Disease in adolescence becomes
characteristically that of adult-type pulmonary tuberculosis,
also called chronic pUlmonary tuberculosis, post-primary or
secondary tuberculosis. Respiratory disease now involves
mainly the apices of the lungs, and cavitation becomes an
integral part of the disease process, contributing not only to
the destruction of lung tissue, but also to the spread of
infection in the community.
An equally curious feature of tuberculosis in adolescence
is the female predominance, which is most obvious under
epidemic conditions.6The risk of developing adult-type
pulmonary tuberculosis in adolescence is 2 - 6 times greater
in females than males and its occurrence is frequently
associated with menarche. 7-9 Notwithstanding this female
predilection for the development of pulmonary tuberculosis,
rates of infection as evinced by a positive tuberculin test are
usually similar for males and females and even show a male
predominance in many studies. lo Despite this well-
documented female predominance in adolescent pulmonary
tuberculosis, tuberculous pleural effusions in adolescence
show a male predominance. 11
The above epidemiological characteristics of tuberculosis
were well known to earlier generations of researchers, but
have been neglected in recent years. Explanations advanced
generally drew upon a vague hormonal or endocrinological
explanation compounded by the metabolic perturbations of
pUberty.4.6.7 Arvid Wallgren therefore stated: 'It is quite likely
that the liability to pUlmonary tuberculosis (in adolescence)
is intimately linked up with endocrine activity. In this way
may also the decreased resistance during pregnancy be
explained ... ." Margaret Smith commented: 'The
depressing effect of puberty in the girl on the retention of
nitrogen and calcium ... may be determining factors in the
higher rate of chronic pulmonary tuberculosis in young
adolescent females. '7
In discussing the potential importance of the factors
involved in this phenomenon, Arnold Rich wrote: 'The most
earnest study should be devoted to an elucidation of the
factors which influence the development of progressive
tuberculosis at this time of life, for the precise reasons for
the disastrous effects observed during this period, and later
in life as a result of infection occurring during this period, are
still for the most part obscure and the problem is one not
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only of extraordinary theoretical interest, but of the utmost
importance from the standpoint of human welfare. '12
Recent developments in our understanding of hormonal
influences upon the immune system have begun to offer
more precise hypotheses for these facts. It now seems
possible that an endocrinological effect upon the capacity of
the immune system to control stationary-phase dormant
tuberculosis bacilli contributes to adolescent susceptibility
to disease and affects the nature of the disease process.13
Two types.of tissue response to the intradermal injection
of tuberculin in an individual previously infected with
Mycobacterium tuberculosis can be identified. Firstly, there
is a non-necrotising response which correlates with
immunity and secondly, a necrotising response, as in the
well-known Koch phenomenon, which does not correlate
closely with protection. '4 Similarly, two subsets of helper
T cells, Th1 and Th2, have been identified, with distinct
profiles of cytokine secretion. '5 In vivo, acting in concert with
other cell types, these give rise to two patterns of cytokine
release known as type 1 (IL-2, IL-12, and gamma-interferon)
and type 2 (IL-4, 5, 6, 10 and 13). The balance of the two
'families' of cytokines may be critical in determining
resistance or progression of HIV infection to AIDS.16 This
balance may be eqUally important in other chronic infections
such as tuberculosis.13 Indeed, evidence from in vivo
cytokine neutralisation experiments and gene knockout mice
supports the view that the type 1 response, which stimulates
cell-mediated immunity, is also needed (J. Flynn and B. R.
Bloom - personal communication), probably as an
additional activator of macrophages. Paradoxically, however,
there are also strong arguments for the view that tumour
necrosis factor alpha (TNFa) is responsible for some of the
necrosis and weight loss in tuberculosis,17 and the recent
observation that administration of thalidomide causes
weight gain and symptomatic relief in tuberculosis patients
lends support to this concept (G. Kaplan - personal
communication), because thalidomide decreases production
of TNFa. The paradox may be resolved by the observation
that whereas TNFa is non-toxic when injected into a
relatively 'pure' type 1 inflammatory site, where it
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presumably contributes to macrophage activation, it causes
necrosis when injected into a mixed type 1 + type 2 site. IS
This may explain the dual role of TNFa in tuberculosis,
because patients show a clear type 1-lo-type 2 shift. For
instance the IL-4 gene is expressed in patients' peripheral
blood T cells1i2ll and there is IgE antibody, which is
dependent on IL-4.21
The balance of type 1-lo-type 2 activity appears to be
regulated by adrenal steroids, so it is logical to seek
explanations for adolescent tuberculosis in the striking
changes in adrenal function that occur at pUberty. At all
ages, the release of IL-l, IL-6 and TNFa from sites of
immunological activity activates the hypothaJamic pituitary
adrenal axis and increases glucocorticoid production.Z2
Glucocorticoids for their part inhibit Th1 activity and
synergise with IL-4, and thus create a bias towards Th2
activity." In contrast to the glucocorticoids, the adrenal
androgen dehydroepiandrosterone (DHEA), or perhaps a
metabolite of DHEA formed in vivo/4 acts as a genuine anti-
glucocorticoicj2!l and also promotes a Th1 response.2e In
tuberculosis and HIV infection a decrease in the
DHEAlcortisol ratio is well documented and in HIV infection
is associated with progression Jo AIDS.1J.21
One would therefore anticipate that a high DHEA/cortisol
ratio would favour a protective type 1 response. However,
what we know of childhood tuberculosis suggests the
reverse correlation. DHEA levels are high during the first year
of life when the risk of disease and mortality from
tuberculosis is highest. DHEA levels remain low from 1 year
until about 8 years of age, during which time the risk of
disease is also decreasing although the risk of infection
remains constant. The rise in the incidence of tuberculous
_disease during adolescence correlates with a rise in DHEA
levels. DHEA secretion throughout childhood and
adolescence is higher in girls than in boys,2:B.2S correlating
with a greater risk of disease in girls in this age group.
Cortisol secretion, however, apart from its diurnal variation,
remains constant during adolescence.
These points lead to some difficu~ but important
questions. First, what is the mechanism of immunity to
tuberculosis in children from 1 to 8 years? Is it a type 1
response? If so, why does it function so well without DHEA?
Is a relevant downstream metabolite of DHEA produced via
a different route in the prepubertal adrenal? The truth is that
we do not know the final effector mechanism even for the
adutt response, since human macrophages have not been
convincingly shown to kill M. tuberculosis, and we know
nothing at all about the mechanisms present in children.
This question clearty deserves investigation.
Secondly, does the increase in DHEA at puberty convert
the response to an adu~ type? If so why does it fail so often,
leading to adu~-typecavitatory disease rather than adu~­
type immunity? Perhaps the failure is an effect of other
hormones that appear at the same time. For instance, there
is some evidence that dihydrotestosterone can
downregulate production of gamma interferon.:JO
A further hormonal factor which may operate during the
period of rapid bone growth in adolescence, and which may
influence the Th1fTh2 balance, is the immunoregulatory role
of vitamin 0 and its metabolites, which function
independently of the control by parathyroid hormone.
Autocrine conversion of 2S-QHD3 to active 1,2S(OH)2D3
(calcitriol) by interleron gamma-activated macrophages
appears to be essential for immunity to tuberculosis.31 The
production of 1,25(OH)2D3 may however be a double-edged
sword as excessive amounts may promote a Th2-type
response with the release of TNFa and tissue necrosis.1U 2
There are few published data on the production of
1.25(OH)2D3 during adolescence, but it is not unlikely that a
surfeit generated by active bone metabolism during this
period of life may affect immunity to tuberculosis.
As our understanding of the factors promoting tissue
necrosis increases so does the possibility of influencing this
process. As it is tissue necrosis and cavitation that promote
the expectoration of large numbers of M. tuberculosis during
coughing, the epidemiological implications of understanding
and controlling the process are considerable. StUdy of the
neuro-endocrinological influences operating in HIV infection
and AIDS has already advanced our understanding of the
functioning of the immune system during chronic disease
processes. The application of similar methodologies in
adolescent tuberculosis may prove equally rewarding.
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OPINION
Compensation for
disabilities
Determining just compensation for disabilities is difficult
even when assessment is by competent and experienced
professionals.
There is much that is unsatisfactory in the mechanisms for
awarding compensation in South Africa As in other
countries which have inherited aspects of English law, the
system in South Africa is adversarial: the court cannot make
judgements unless the facts are presented by opposing
parties. Controversy is necessary to allow the courts to hear
the matter. The system creates adversaries, even where
none should exist, so that what should be a dispassionate
judgement of disability becomes a contest of strength.
Separate court systems exist for liquor licensing, income
tax, industri.al relations, workmen's compensation and water
affairs because these fields have specialised complexity, but
ij is the general courts which pass judgement on subtle and
intricate medical issues - almost always without the benefit
of a medical expert sitting with the jUdge.
A further complication is that the medical aspect (Which
entails the quantification of disability, comprising about 80%
of the case) and the legal aspect (determining fau~) tend to
fuse. As a result, the medical profession's role in quantifying
disability has largely yielded to the lawyer's adversarial
detenninations.
The medical assessor, who would be an appropriate and
effective executive authority in assessing disability, has been
replaced in the adversarial system by the medical wijness
who plays little more than a subservient role - instructed,
recruited or excluded as it best serves the lawyer. The
medical witness is often drawn into the proceedings by
chance, civic duty or innocent helpfulness. He is thrust into
an adversariaJ interchange with which he is unaccustomed
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and placed under stress in the unfamiliar territory of a court
of law. At times he is unpleasantly harried by cross-
examination when legal techniques are used in attempts to
discredit or unsettle his medical judgements_ He is then
expected to be objectively and articulately instructive toward
lawyer. advocate and judge in matters medical.
After this, lawyer and judge claim to have acquired a
knowledge of the science, experience, interpretive subtleties
and inturtions necessary to make medical judgements. Not
surprisingly misapprehensions occur, and when court
judgements are appraised from a medical point of view,
inappropriate awards seem to occur trequentty.
As a result of the abovementioned factors, and pertlaps
others. many medical people are reluctant to appear on
behalf of the injured party.
A number of factors further militate against just awards of
compensation: these include population ignorance, lawyer
workload or lawyer inexperience, fraud and the costs and
financial risks of Supreme Court action. If, in addition, the
claimant has diffiCUlty in obtaining sincere medical witnesses
of an appropriate calibre to support his claim, the current
process of claiming compensation may well degenerate. The
outcome could be an increase in fraudulent claims,
contingency litigation (percentage of award to lawyer) and
the use of 'hired gun' medical witnesses.
I believe that, under the present system, there is a grave
danger that the disincentives to make claims for disabilities
could become so great as to jeopardise just compensation
of the disabled.
It is the medical profession's responsibility to close this
unsatisfactory gap in the health sciences and to reclaim the
role of impartial assessors of disability and compensation -
with appropriate legal assistance (rather than legal controO.
The realist will recognise that it is far easier to familiarise a
medical expert with the adjunctive areas of law - which are
fairly consistent - than it is for a medical expert repetitiVely
to instruct a court on matters medical, a different (and
expensive) exercise with each different injury and each
drtferent case.
The appropriate route for the medical profession could be
via techniques of dispute mediation or arbitration. 'No faulf
compensation has many commendable advantages and
strong support from the medical profession will be
necessary for the concept to gain ground.
To improve the accuracy and expedition of disability
compensation the medical profession needs to address the
training of medical personnel as assessors of disability. The
skills and science of appraising handicap require
development along with awareness of the monetary and
impedimentary value of the losses caused by disablement.
These needs would best be served by the establishment of
an institute for the measurement of disability, where
objective methods of measuring disability could be
researched, developed and taught, and disability appraised
by skilled, eclectic professionals. Support from the
insurance industry would more than pay for itself and benefit
that industry and society as a whole.
J, p, Driver-Jowitt
Orthopa.edic Surgeon
3 Norfolk Read
Newlands
Cape Town
SAMJ Voll.lm!' 86 No. 3 March 1996
